Login / Signup

Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies.

Alexis C BoulterBarry J MaurerMeredith PogueMin H KangHwangeui ChoAmanda KnightC Patrick ReynoldsDonald QuickSanjay AwasthiDavid E Gerber
Published in: Cancer chemotherapy and pharmacology (2023)
NCT01553071 (3.13.2012).
Keyphrases
  • phase iii
  • study protocol
  • high dose
  • phase ii
  • clinical trial